Substantial alterations at the multi-omics level of pancreatic cancer (PC) impede the
possibility to diagnose and treat patients in early stages. Herein, we conducted an …

Background microRNA (miRNA) expression plays an influential role in cancer classification
and malignancy, and miRNAs are feasible as alternative diagnostic markers for pancreatic …

Background The hunt for the molecular markers with specificity and sensitivity has been a
hot area for the tumor treatment. Due to the poor diagnosis and prognosis of pancreatic …

Predicting the prognosis of pancreatic cancer is important because of the very low survival
rates of patients with this particular cancer. Although several studies have used microRNA …

Pancreatic cancer (PC) is one of the leading causes of cancer-related death globally. So,
identification of potential molecular signatures is required for diagnosis, prognosis, and …

Pancreatic cancer is one of the most fatal malignancies and the seventh leading cause of
cancer-related deaths related to late diagnosis, poor survival rates, and high incidence of …

Background Pancreatic cancer is an aggressive cancer with dismal prognosis, urgently
necessitating better biomarkers to improve therapeutic options and early diagnosis …

Pancreatic carcinoma (PC) is a severe disease associated with high mortality. Although
strategies for cancer therapy have made great progress, outcomes of pancreatic carcinoma …

Oxidative stress (OS), which impacts lipid metabolic reprogramming, can affect the biological
activities of cancer cells. How oxidative stress and phospholipid metabolism (OSPM) …

Background Pancreatic ductal adenocarcinoma (PDAC) is a fatal malignant neoplasm. It is
necessary to improve the understanding of the underlying molecular mechanisms and …